Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
McKinsey
Express Scripts
Mallinckrodt
Dow

Last Updated: January 21, 2020

DrugPatentWatch Database Preview

Novast Labs Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for NOVAST LABS, and what generic and branded alternatives to NOVAST LABS drugs are available?

NOVAST LABS has fifty-eight approved drugs.

There are three tentative approvals on NOVAST LABS drugs.

Summary for Novast Labs
US Patents:0
Tradenames:56
Ingredients:42
NDAs:58

Drugs and US Patents for Novast Labs

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novast Labs LIDOCAINE lidocaine OINTMENT;TOPICAL 208604-001 Sep 20, 2017 AT RX No No   Start Trial   Start Trial
Novast Labs Ltd MONO-LINYAH ethinyl estradiol; norgestimate TABLET;ORAL-28 090523-001 May 23, 2012 AB RX No No   Start Trial   Start Trial
Novast Labs Ltd ELINEST ethinyl estradiol; norgestrel TABLET;ORAL-28 091105-001 Mar 28, 2012 AB RX No No   Start Trial   Start Trial
Novast Labs METOPROLOL SUCCINATE metoprolol succinate TABLET, EXTENDED RELEASE;ORAL 204106-004 Feb 6, 2018 AB RX No No   Start Trial   Start Trial
Novast Labs TIZANIDINE HYDROCHLORIDE tizanidine hydrochloride CAPSULE;ORAL 210267-001 Mar 12, 2019 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Johnson and Johnson
Baxter
Mallinckrodt
Express Scripts
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.